Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasm Metastasis 1Breast Neoplasms 1

Interventions

Specimen Handling 4Biopsy 4Magnetic Resonance Spectroscopy 3vactosertib 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1pegamotecan 1neratinib 1ipatasertib 1fludarabine phosphate 1binimetinib 1aldesleukin 1X-Rays 1Trastuzumab 1Taxes 1Surveys and Questionnaires 1Phantoms, Imaging 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Nivolumab 1NUC-1031 1N-acetylcochinol-O-phosphate 1Ipilimumab 1Interleukin-2 1IL32 protein, human 1Gemcitabine 1Cyclophosphamide 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Neoplasm Metastasis × Acetic Acid × Clear all
NCT04120246 2024-07-10

Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

Veana Therapeutics

Phase 1 Suspended
24 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡